Skip to main content
. 2021 Aug 20;374:n2015. doi: 10.1136/bmj.n2015

Fig 3.

Fig 3

Adjusted vaccine effectiveness ≥14 days after the second dose of CoronaVac (Sinovac Biotech) for subgroups of adults aged ≥70 years. Estimates of vaccine effectiveness were obtained from a conditional logistic regression model that included covariates of age and number of comorbidities and incorporated an interaction term between the category of interest and the period ≥14 days after the second dose